These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7448327)

  • 1. Estradiol and progersterone receptors in F1 (C3H X RIII) mice mammary tumors: effect of castration.
    Edery M; Drosdowsky MA
    Biomedicine; 1980 May; 33(3):80-2. PubMed ID: 7448327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between prolactin and ovarian secretions during mammary tumorigenesis in the mouse.
    Edery M; Goussard J; Vives C; Rudali G; Drosdowsky MA
    Biomedicine; 1980 Dec; 33(8):265-7. PubMed ID: 7213925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
    Diamond EJ; Giladi M; Khan S; Hollander VP
    Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen dependence of mammary gland tumors: the mechanisms of the disorder and the evaluation criteria].
    Merkulova TI; Morozova TM; Sakganik RI
    Vopr Onkol; 1980; 26(10):67-75. PubMed ID: 7434681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of pharmacological doses of estrogen-dependent mammary tumors with estrogen and progesterone receptors.
    Yoshida H; Yoshida A; Noguchi S; Matsumoto K
    In Vivo; 1987; 1(3):157-61. PubMed ID: 2979780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estradiol reception and enzyme induction in mouse mammary gland neoplasms].
    Merkulova TI; Morozova TM; Iakovleva GE; Salganik RI
    Vopr Onkol; 1978; 24(8):19-26. PubMed ID: 695420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Shafie SM; Hilf R
    Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormone receptors in mammary carcinoma: the effect of tamoxifen.
    Koenders AJ; Beex LV; Geurts-Moespot J; Benraad TJ
    Eur J Cancer (1965); 1980; Suppl 1():63-6. PubMed ID: 7318871
    [No Abstract]   [Full Text] [Related]  

  • 10. Steroid-hormone-binding proteins in normal and neoplastic mammary tissues from C3H mice fed diethylstilbestrol.
    Lewko WM; Wittliff JL
    J Toxicol Environ Health; 1983 Jul; 12(1):127-41. PubMed ID: 6632000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid metabolism and steroid receptors in dimethylbenz(a)anthracene-induced rat mammary tumors.
    Eechaute W; de Thibault de Boesinghe L; Lacroix E
    Cancer Res; 1983 Sep; 43(9):4260-5. PubMed ID: 6409401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
    Turcot-Lemay L; Kelly PA
    Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
    [No Abstract]   [Full Text] [Related]  

  • 13. The biochemical mechanisms of the stimulating action of estradiol on the growth of mammary tumours.
    Morozova TM; Mitina RL; Nagibneva IN; Ozhogina ZB; Salganik RI
    Exp Clin Endocrinol; 1986 Dec; 88(3):293-302. PubMed ID: 3030784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of malignant breast tumors containing estrogen receptors].
    El'tsina NV
    Vopr Onkol; 1982; 28(4):95-102. PubMed ID: 7046238
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of effect of dietary fat on the growth and estrogen sensitivity of the MT-W9B transplantable mammary tumor.
    Ip MM; Ip C
    Nutr Cancer; 1981; 3(1):27-34. PubMed ID: 7346787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pharmacological doses of estrogen on ovary-independent rat mammary carcinoma containing estrogen and progesterone receptors.
    Yoshida H; Fukuhara T; Yamashi S; Yoshida A; Fukunishi R; Tsuji M; Matsumoto K
    Cancer Res; 1983 May; 43(5):2311-6. PubMed ID: 6403234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115.
    Noguchi S; Kitamura Y; Uchida N; Yamaguchi K; Sato B; Matsumoto K
    Cancer Res; 1984 Dec; 44(12 Pt 1):5644-9. PubMed ID: 6498825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.
    Matsuzawa A; Kaneko T; Ikeda Y
    Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammary cancer: selective action of the estrogen receptor complex.
    Ip M; Milholland RJ; Rosen F; Kim U
    Science; 1979 Jan; 203(4378):361-3. PubMed ID: 760195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.